These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 6209016)

  • 21. Duration of immunity: an anamnestic response 14 years after rabies vaccination with purified chick embryo cell rabies vaccine.
    Malerczyk C; Briggs DJ; Dreesen DW; Banzhoff A
    J Travel Med; 2007; 14(1):63-4. PubMed ID: 17241256
    [No Abstract]   [Full Text] [Related]  

  • 22. Maternal antibodies against rabies in Thai puppies. A preliminary study.
    Kasempimolporn S; Mitmoonpitak C; Chaiyabutr N; Supakorn K; Brahmasa R; Sitprija V
    J Med Assoc Thai; 1996 Jan; 79(1):36-9. PubMed ID: 8867400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fox rabies in India.
    Wilde H
    Clin Infect Dis; 2005 Feb; 40(4):614-5. PubMed ID: 15712087
    [No Abstract]   [Full Text] [Related]  

  • 24. Failure of multiple-site intradermal postexposure rabies vaccination in patients with human immunodeficiency virus with low CD4+ T lymphocyte counts.
    Tantawichien T; Jaijaroensup W; Khawplod P; Sitprija V
    Clin Infect Dis; 2001 Nov; 33(10):E122-4. PubMed ID: 11641838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Investigation of antibody levels following rabies vaccination in the subjects who were biten by animals].
    Baysal B; Tosun S; Ozdemir M; Doğan M
    Mikrobiyol Bul; 2009 Jan; 43(1):127-31. PubMed ID: 19334389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and evaluation of a competitive ELISA for estimation of rabies neutralizing antibodies after post-exposure rabies vaccination in humans.
    Muhamuda K; Madhusudana SN; Ravi V
    Int J Infect Dis; 2007 Sep; 11(5):441-5. PubMed ID: 17321182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and characterization of human neutralizing antibodies to rabies virus derived from a recombinant immune antibody library.
    Houimel M; Dellagi K
    J Virol Methods; 2009 Nov; 161(2):205-15. PubMed ID: 19559727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production, purification and analysis of an experimental DNA vaccine against rabies.
    Diogo MM; Ribeiro SC; Queiroz JA; Monteiro GA; Tordo N; Perrin P; Prazeres DM
    J Gene Med; 2001; 3(6):577-84. PubMed ID: 11778904
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation and standardization of virus neutralizing test using indirect immunoperoxidase technique for the quantification of antibodies to rabies virus.
    Ogawa T; Gamoh K; Aoki H; Kobayashi R; Etoh M; Senda M; Hirayama N; Nishimura M; Shiraishi R; Servat A; Cliquet F
    Zoonoses Public Health; 2008 Aug; 55(6):323-7. PubMed ID: 18489544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2.
    Patial S; Chaturvedi VK; Rai A; Saini M; Chandra R; Saini Y; Gupta PK
    Vaccine; 2007 May; 25(20):4020-8. PubMed ID: 17391817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific activity of concentrated and purified cell culture rabies vaccine (CPCRV) from the strain Vnukovo -32-107 in an experiment with therapeutical immunization of humans.
    Selimov M; El'bert L; Aksenova T; Klyueva E; Gribencha L; Movsesyants A; Antonova L; Kamenetskaya I; Mishchenko N; Krupenin L; Bugayeva M; Yaretskaya V; Pyaeva A
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(1):83-94. PubMed ID: 7086124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serological effect after immunization with rabies vaccine of different doses].
    Chen AZ; Kong FJ; Mei ZQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 1996 Jun; 17(3):139-40. PubMed ID: 9208508
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune responses to nucleic acid vaccines to rabies virus.
    Xiang ZQ; Spitalnik SL; Cheng J; Erikson J; Wojczyk B; Ertl HC
    Virology; 1995 Jun; 209(2):569-79. PubMed ID: 7778289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of homologous vs. heterologous challenge virus strains on the serological test results of rabies virus neutralizing assays.
    Moore SM; Ricke TA; Davis RD; Briggs DJ
    Biologicals; 2005 Dec; 33(4):269-76. PubMed ID: 16168666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential effect of prior raccoonpox virus infection in raccoons on vaccinia-based rabies immunization.
    Root JJ; McLean RG; Slate D; MacCarthy KA; Osorio JE
    BMC Immunol; 2008 Oct; 9():57. PubMed ID: 18834520
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A DNA vaccine that encodes rabies virus glycoprotein lacking transmembrane domain enhances antibody response but not protection.
    Gupta PK; Sharma S; Walunj SS; Patil AA; Rai A; Saini M
    Acta Virol; 2006; 50(2):87-92. PubMed ID: 16808325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Competitive ELISA using a rabies glycoprotein-transformed cell line to semi-quantify rabies neutralizing-related antibodies in dogs.
    Zhang S; Liu Y; Zhang F; Hu R
    Vaccine; 2009 Mar; 27(15):2108-13. PubMed ID: 19356613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Canine adenovirus based rabies vaccines.
    Tordo N; Foumier A; Jallet C; Szelechowski M; Klonjkowski B; Eloit M
    Dev Biol (Basel); 2008; 131():467-76. PubMed ID: 18634509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroimmunology.
    Arnason BG
    N Engl J Med; 1987 Feb; 316(7):406-8. PubMed ID: 2433583
    [No Abstract]   [Full Text] [Related]  

  • 40. Rabies DNA vaccination by the intranasal route in dogs.
    Tesoro Cruz E; Hernández González R; Alonso Morales R; Aguilar-Setién A
    Dev Biol (Basel); 2006; 125():221-31. PubMed ID: 16878480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.